当前位置:产品>信号通路产品>抑制剂>产品详情

FTY720(Fingolimod)
Catalog Number: E1KS5002
Amount: 100mg1​ PHYSICAL AND CHEMICAL PROPERTIES
Applications: Reactivity:
产品类型: Unconjugated
发货周期: 现货
说明书:     PDF
总价格:    151.2元
选择数量:

-
+

咨询客服
概述
  • Catalog Number:

    E1KS5002
  • Amount:

    100mg1​ PHYSICAL AND CHEMICAL PROPERTIES

2​ Biological Activity
FTY720(Fingolimod) is a potent sphingosine-1-phosphate (S1P) receptors agonist with IC50 of 0.137, 10.98 nM for (S)- and (R)- FTY720-phosphate, respectively and reverses the effects of BCR-ABL kinase. It is a novel immunomodulating agent and can sequester lymphocytes in lymph nodes, preventing them from moving to the central nervous system for auto-immune responses in multiple sclerosis and was originally proposed as a anti-rejection medication indicated post-transplantation. [1] It can be phosphorylated by sphingosine kinase and prevents disease in a mouse model of many leukemias caused by BCR-ABL. It does not directly target the BCR-ABL kinase, but instead activates phosphatase 2A (PP2A) which is a tumor suppressor that is inactivated by BCR-ABL. [2] FTY720(Fingolimod) also mediated antitumor effects in hepatocellular carcinoma (HCC) cells by activating PKC . The three HCC cell lines examined, Hep3B, Huh7, and PLC5, exhibited differential susceptibility to FTY720-mediated suppression of cell viability, with IC50 values of 4.5, 6.3, and 11 μM, respectively. [3]
3​ References:
[1] http://en.wikipedia.org/wiki/Fingolimod
[2] Neviani P et al. J Clin Invest. 2007 Sep;117(9):2408-21.
[3] Hung JH et al. Cancer Res. 2008 Feb 15;68(4):1204-12.
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.

2​ Biological Activity FTY720(Fingolimod) is a potent sphingosine-1-phosphate (S1P) receptors agonist with IC50 of 0.137, 10.98 nM for (S)- and (R)- FTY720-phosphate, respectively and reverses the effects of BCR-ABL kinase. It is a novel immunomodulating agent and can sequester lymphocytes in lymph nodes, preventing them from moving to the central nervous system for auto-immune responses in multiple sclerosis and was originally proposed as a anti-rejection medication indicated post-transplantation. [1] It can be phosphorylated by sphingosine kinase and prevents disease in a mouse model of many leukemias caused by BCR-ABL. It does not directly target the BCR-ABL kinase, but instead activates phosphatase 2A (PP2A) which is a tumor suppressor that is inactivated by BCR-ABL. [2] FTY720(Fingolimod) also mediated antitumor effects in hepatocellular carcinoma (HCC) cells by activating PKC . The three HCC cell lines examined, Hep3B, Huh7, and PLC5, exhibited differential susceptibility to FTY720-mediated suppression of cell viability, with IC50 values of 4.5, 6.3, and 11 μM, respectively. [3] 3​ References: [1] http://en.wikipedia.org/wiki/Fingolimod [2] Neviani P et al. J Clin Invest. 2007 Sep;117(9):2408-21. [3] Hung JH et al. Cancer Res. 2008 Feb 15;68(4):1204-12. The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.

相关推荐

Responsive image
WP1130   
Catalog Number:E1KS2243
Amount:10mg
Reactivity:
Applications:    
Swiss-Prot No.
Price:151.2元
Responsive image
SB-408124   
Catalog Number:E1KS1545
Amount:5mg
Reactivity:
Applications:    
Swiss-Prot No.
Price:151.2元
Responsive image
Catalog Number:E1KS1397
Amount:10mg
Reactivity:
Applications:    
Swiss-Prot No.
Price:151.2元